AU Patent

AU2010316683B2 — Tablet formulations of neratinib maleate

Assigned to Wyeth LLC · Expires 2015-10-08 · 11y expired

What this patent protects

The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.

USPTO Abstract

The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010316683B2
Jurisdiction
AU
Classification
—
Expires
2015-10-08
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.